Kaulfuβ and colleagues reported that dual silencing of insulin-like growth factor receptor and epidermal growth factor receptor resulted in an increased apoptosis rate and inhibition of cell proliferation in colorectal cancer cells. Here, EGFR is linked to colorectal cancer.